• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑制白介素-17 可阻止创伤性异位骨化的进展。

Inhibition of IL-17 prevents the progression of traumatic heterotopic ossification.

机构信息

Department of Orthopaedics, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, China.

Department of Sports Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.

出版信息

J Cell Mol Med. 2021 Aug;25(16):7709-7719. doi: 10.1111/jcmm.16617. Epub 2021 Jun 29.

DOI:10.1111/jcmm.16617
PMID:34189826
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8358870/
Abstract

Traumatic heterotopic ossification (HO) is the abnormal formation of bone in soft tissues as a consequence of injury. However, the pathological mechanisms leading to traumatic HO remain unknown. Here, we report that aberrant expression of IL-17 promotes traumatic HO formation by activating β-catenin signalling in mouse model. We found that elevated IL-17 and β-catenin levels are correlated with a high degree of HO formation in specimens from patients and HO animals. We also show that IL-17 initiates and promotes HO progression in mice. Local injection of an IL-17 neutralizing antibody attenuates ectopic bone formation in a traumatic mouse model. IL-17 enhances the osteoblastic differentiation of mesenchymal stem cells (MSCs) by activating β-catenin signalling. Moreover, inhibition of IL-17R or β-catenin signalling by neutralizing antibodies or drugs prevents the osteogenic differentiation of isolated MSCs and decreases HO formation in mouse models. Together, our study identifies a novel role for active IL-17 as the inducer and promoter of ectopic bone formation and suggests that IL-17 inhibition might be a potential therapeutic target in traumatic HO.

摘要

创伤性异位骨化(HO)是由于损伤导致骨在软组织中异常形成。然而,导致创伤性 HO 的病理机制尚不清楚。在这里,我们报告异常表达的白细胞介素-17(IL-17)通过激活β-连环蛋白信号通路促进小鼠模型中创伤性 HO 的形成。我们发现,在患者和 HO 动物的标本中,升高的 IL-17 和 β-连环蛋白水平与 HO 形成的高度相关。我们还表明,IL-17 在小鼠中启动并促进 HO 的进展。局部注射白细胞介素-17 中和抗体可减轻创伤性小鼠模型中的异位骨形成。IL-17 通过激活β-连环蛋白信号通路增强间充质干细胞(MSCs)的成骨分化。此外,通过中和抗体或药物抑制 IL-17R 或β-连环蛋白信号通路可防止分离的 MSCs 的成骨分化,并减少小鼠模型中的 HO 形成。总之,我们的研究确定了活跃的白细胞介素-17 作为异位骨形成的诱导剂和促进剂的新作用,并表明白细胞介素-17 抑制可能是创伤性 HO 的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/813e/8358870/0e7a065ecb2f/JCMM-25-7709-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/813e/8358870/8b977705c0bb/JCMM-25-7709-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/813e/8358870/c5bf7cc975fc/JCMM-25-7709-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/813e/8358870/0d4ca2f92c33/JCMM-25-7709-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/813e/8358870/2d3ab03d795e/JCMM-25-7709-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/813e/8358870/0e7a065ecb2f/JCMM-25-7709-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/813e/8358870/8b977705c0bb/JCMM-25-7709-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/813e/8358870/c5bf7cc975fc/JCMM-25-7709-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/813e/8358870/0d4ca2f92c33/JCMM-25-7709-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/813e/8358870/2d3ab03d795e/JCMM-25-7709-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/813e/8358870/0e7a065ecb2f/JCMM-25-7709-g005.jpg

相似文献

1
Inhibition of IL-17 prevents the progression of traumatic heterotopic ossification.抑制白介素-17 可阻止创伤性异位骨化的进展。
J Cell Mol Med. 2021 Aug;25(16):7709-7719. doi: 10.1111/jcmm.16617. Epub 2021 Jun 29.
2
Inhibition of overactive TGF-β attenuates progression of heterotopic ossification in mice.抑制过度活跃的 TGF-β 可减轻小鼠异位骨化的进展。
Nat Commun. 2018 Feb 7;9(1):551. doi: 10.1038/s41467-018-02988-5.
3
BMP Ligand Trap ALK3-Fc Attenuates Osteogenesis and Heterotopic Ossification in Blast-Related Lower Extremity Trauma.骨形态发生蛋白配体陷阱ALK3-Fc减轻爆炸相关下肢创伤中的骨生成和异位骨化。
Stem Cells Dev. 2021 Jan 15;30(2):91-105. doi: 10.1089/scd.2020.0162. Epub 2020 Dec 24.
4
Treatment of heterotopic ossification through remote ATP hydrolysis.通过远程ATP水解治疗异位骨化。
Sci Transl Med. 2014 Sep 24;6(255):255ra132. doi: 10.1126/scitranslmed.3008810.
5
Macrophage-Derived TGF-β and VEGF Promote the Progression of Trauma-Induced Heterotopic Ossification.巨噬细胞衍生的转化生长因子-β和血管内皮生长因子促进创伤性异位骨化的进展。
Inflammation. 2023 Feb;46(1):202-216. doi: 10.1007/s10753-022-01723-z. Epub 2022 Aug 20.
6
High Frequency Spectral Ultrasound Imaging Detects Early Heterotopic Ossification in Rodents.高频超声光谱成像可检测啮齿动物的早期异位骨化。
Stem Cells Dev. 2021 May 1;30(9):473-484. doi: 10.1089/scd.2021.0011. Epub 2021 Apr 19.
7
Involvement of the Wnt/β-catenin signalling pathway in heterotopic ossification and ossification-related diseases.Wnt/β-catenin 信号通路在异位骨化和骨化相关疾病中的作用。
J Cell Mol Med. 2024 Sep;28(18):e70113. doi: 10.1111/jcmm.70113.
8
Effects of aging on osteogenic response and heterotopic ossification following burn injury in mice.衰老对小鼠烧伤后成骨反应和异位骨化的影响。
Stem Cells Dev. 2015 Jan 15;24(2):205-13. doi: 10.1089/scd.2014.0291.
9
Human osteoprogenitor cells obtained from traumatic heterotopic ossification samples showed enhanced osteogenic differentiation potential and ERK/hedgehog signaling than that from normal bone.从创伤性异位骨化样本中获得的人成骨前体细胞表现出比正常骨更高的成骨分化潜力和 ERK/ hedgehog 信号。
IUBMB Life. 2022 Nov;74(11):1081-1093. doi: 10.1002/iub.2670. Epub 2022 Aug 27.
10
Berberine and aspirin prevent traumatic heterotopic ossification by inhibition of BMP signalling pathway and osteogenic differentiation.小檗碱和阿司匹林通过抑制 BMP 信号通路和成骨分化来预防创伤性异位骨化。
J Cell Mol Med. 2023 Nov;27(22):3491-3502. doi: 10.1111/jcmm.17919. Epub 2023 Aug 22.

引用本文的文献

1
The Function and Mechanism of Anti-Inflammatory Factor Metrnl Prevents the Progression of Inflammatory-Mediated Pathological Bone Osteolytic Diseases.抗炎因子Metrnl预防炎症介导的病理性骨溶解疾病进展的功能及机制
J Inflamm Res. 2024 Mar 11;17:1607-1619. doi: 10.2147/JIR.S455790. eCollection 2024.
2
Inflammation-Responsive Hydrogel Spray for Synergistic Prevention of Traumatic Heterotopic Ossification via Dual-Homeostatic Modulation Strategy.炎症响应型水凝胶喷雾通过双重稳态调节策略协同预防创伤性异位骨化。
Adv Sci (Weinh). 2023 Oct;10(30):e2302905. doi: 10.1002/advs.202302905. Epub 2023 Aug 27.
3
lncRNA MEG3 Promotes Osteogenic Differentiation of Tendon Stem Cells Via the miR-129-5p/TCF4/β-Catenin Axis and thus Contributes to Trauma-Induced Heterotopic Ossification.

本文引用的文献

1
The IL-17 Family of Cytokines in Health and Disease.白细胞介素-17 细胞因子家族在健康和疾病中的作用。
Immunity. 2019 Apr 16;50(4):892-906. doi: 10.1016/j.immuni.2019.03.021.
2
Targeting IL-17 attenuates hypoxia-induced pulmonary hypertension through downregulation of β-catenin.靶向白细胞介素-17 通过下调β-连环蛋白减轻低氧诱导的肺动脉高压。
Thorax. 2019 Jun;74(6):564-578. doi: 10.1136/thoraxjnl-2018-211846. Epub 2019 Feb 18.
3
Effects of the IL-23-IL-17 pathway on bone in spondyloarthritis.IL-23-IL-17 通路在脊柱关节炎中对骨骼的影响。
长链非编码RNA MEG3通过miR-129-5p/TCF4/β-连环蛋白轴促进肌腱干细胞的成骨分化,从而导致创伤性异位骨化。
Stem Cell Rev Rep. 2023 Oct;19(7):2311-2328. doi: 10.1007/s12015-023-10562-w. Epub 2023 Jun 7.
4
Macrophage-Derived TGF-β and VEGF Promote the Progression of Trauma-Induced Heterotopic Ossification.巨噬细胞衍生的转化生长因子-β和血管内皮生长因子促进创伤性异位骨化的进展。
Inflammation. 2023 Feb;46(1):202-216. doi: 10.1007/s10753-022-01723-z. Epub 2022 Aug 20.
Nat Rev Rheumatol. 2018 Nov;14(11):631-640. doi: 10.1038/s41584-018-0091-8.
4
Challenges of heterotopic ossification-Molecular background and current treatment strategies.异位骨化的挑战-分子背景和当前的治疗策略。
Clin Exp Pharmacol Physiol. 2018 Dec;45(12):1229-1235. doi: 10.1111/1440-1681.13025. Epub 2018 Oct 4.
5
Characterizing the Circulating Cell Populations in Traumatic Heterotopic Ossification.描述创伤性异位骨化中的循环细胞群体。
Am J Pathol. 2018 Nov;188(11):2464-2473. doi: 10.1016/j.ajpath.2018.07.014. Epub 2018 Aug 22.
6
IL-17A induces osteoblast differentiation by activating JAK2/STAT3 in ankylosing spondylitis.IL-17A 通过激活 JAK2/STAT3 诱导强直性脊柱炎成骨细胞分化。
Arthritis Res Ther. 2018 Jun 7;20(1):115. doi: 10.1186/s13075-018-1582-3.
7
Acquired and congenital forms of heterotopic ossification: new pathogenic insights and therapeutic opportunities.获得性和先天性异位骨化:新的发病机制见解和治疗机会。
Curr Opin Pharmacol. 2018 Jun;40:51-58. doi: 10.1016/j.coph.2018.03.007. Epub 2018 Mar 31.
8
Stem cells and heterotopic ossification: Lessons from animal models.干细胞与异位骨化:动物模型的启示。
Bone. 2018 Apr;109:178-186. doi: 10.1016/j.bone.2018.01.029. Epub 2018 Jan 31.
9
Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3.司库奇尤单抗治疗活动性强直性脊柱炎的疗效、安全性和耐受性:一项随机、双盲、III 期研究,MEASURE 3。
Arthritis Res Ther. 2017 Dec 22;19(1):285. doi: 10.1186/s13075-017-1490-y.
10
Post-Traumatic Heterotopic Ossification: An Old Problem in Need of New Solutions.创伤后异位骨化:一个亟待新解决方案的老问题。
J Orthop Res. 2018 Apr;36(4):1061-1068. doi: 10.1002/jor.23808. Epub 2017 Dec 19.